Jerome Benedict Durso - 31 Dec 2021 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC.

Role
President & CEO, Director
Signature
/s/ Rocco Venezia, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
31 Dec 2021
Net transactions value
-$96,779
Form type
4
Filing time
04 Jan 2022, 15:16:14 UTC
Previous filing
05 Oct 2021
Next filing
31 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICPT Common Stock Tax liability $91,338 -5,607 -6.9% $16.29 75,957 31 Dec 2021 Direct F1
transaction ICPT Common Stock Tax liability $5,441 -334 -0.44% $16.29 75,623 01 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person.